| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.36 | 0.04 |